2015 Q1 Form 10-Q Financial Statement

#000114420415031315 Filed on May 15, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q1
Revenue $525.8K $970.0K $374.9K
YoY Change 40.27% -29.2% -39.07%
Cost Of Revenue $360.0K $690.0K $210.5K
YoY Change 70.99% -34.91% -62.73%
Gross Profit $167.1K $280.0K $164.3K
YoY Change 1.7% -9.68% 226.87%
Gross Profit Margin 31.78% 28.87% 43.84%
Selling, General & Admin $1.250M
YoY Change -80.97%
% of Gross Profit 446.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $57.13K $60.00K $54.32K
YoY Change 5.16% 20.0% -4.83%
% of Gross Profit 34.18% 21.43% 33.06%
Operating Expenses $1.016M $1.260M $1.528M
YoY Change -33.5% -38.54% 20.19%
Operating Profit -$848.8K -$980.0K -$1.363M
YoY Change -37.74% -43.68% 11.68%
Interest Expense $38.03K -$150.0K $56.00K
YoY Change -32.09% -400.0% 199.01%
% of Operating Profit
Other Income/Expense, Net $9.427K -$42.17K
YoY Change -122.36% 19.05%
Pretax Income -$839.4K -$1.460M -$1.406M
YoY Change -40.28% -42.29% 11.89%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$839.4K -$1.460M -$1.406M
YoY Change -40.28% -40.65% 11.89%
Net Earnings / Revenue -159.63% -150.52% -374.95%
Basic Earnings Per Share -$0.03 -$0.05
Diluted Earnings Per Share -$30.70K -$53.46K -$52.73K
COMMON SHARES
Basic Shares Outstanding 27.31M shares 27.31M shares 26.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.570M $250.0K $910.0K
YoY Change 72.53% -55.36% -46.78%
Cash & Equivalents $1.574M $87.90K $914.8K
Short-Term Investments $160.0K
Other Short-Term Assets $694.4K $647.7K $426.9K
YoY Change 62.64% 301.61% -71.73%
Inventory $469.2K $387.9K $394.4K
Prepaid Expenses
Receivables $573.7K $358.8K $354.9K
Other Receivables $0.00 $110.0K $0.00
Total Short-Term Assets $4.200M $2.461M $3.193M
YoY Change 31.53% -4.81% -21.55%
LONG-TERM ASSETS
Property, Plant & Equipment $445.2K $532.5K $558.3K
YoY Change -20.26% 13.02% 16.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $50.00K
YoY Change
Other Assets $188.8K $364.3K $388.5K
YoY Change -51.39% -23.41% 253.14%
Total Long-Term Assets $755.7K $1.023M $1.088M
YoY Change -30.57% -6.4% -31.44%
TOTAL ASSETS
Total Short-Term Assets $4.200M $2.461M $3.193M
Total Long-Term Assets $755.7K $1.023M $1.088M
Total Assets $4.955M $3.485M $4.281M
YoY Change 15.74% -5.28% -24.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.960M $2.166M $2.255M
YoY Change -13.09% -8.16% 14.46%
Accrued Expenses $970.0K
YoY Change -41.26%
Deferred Revenue
YoY Change
Short-Term Debt $1.114M $1.081M $522.5K
YoY Change 113.15% 1692.14% 16.11%
Long-Term Debt Due $10.00K $34.61K $140.0K
YoY Change -92.86% -78.92% 100.0%
Total Short-Term Liabilities $3.593M $3.968M $3.101M
YoY Change 15.86% 45.74% 9.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $1.846M
YoY Change -100.0% -100.0% 3592.44%
Other Long-Term Liabilities $370.0K $270.0K $120.0K
YoY Change 208.33% 285.71%
Total Long-Term Liabilities $370.0K $0.00 $1.846M
YoY Change -79.96% -100.0% 3592.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.593M $3.968M $3.101M
Total Long-Term Liabilities $370.0K $0.00 $1.846M
Total Liabilities $3.960M $3.968M $4.947M
YoY Change -19.95% 28.54% 71.18%
SHAREHOLDERS EQUITY
Retained Earnings -$28.33M -$27.49M -$23.21M
YoY Change 22.07% 26.09%
Common Stock $29.85M $27.26M $22.46M
YoY Change 32.93% 21.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $994.6K -$756.4K -$783.9K
YoY Change
Total Liabilities & Shareholders Equity $4.955M $3.485M $4.281M
YoY Change 15.74% -5.28% -24.36%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q1
OPERATING ACTIVITIES
Net Income -$839.4K -$1.460M -$1.406M
YoY Change -40.28% -40.65% 11.89%
Depreciation, Depletion And Amortization $57.13K $60.00K $54.32K
YoY Change 5.16% 20.0% -4.83%
Cash From Operating Activities -$1.288M -$800.0K -$1.512M
YoY Change -14.84% 3.9% 789.37%
INVESTING ACTIVITIES
Capital Expenditures $2.872K -$20.00K $137.1K
YoY Change -97.91% -71.43% 723.3%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.872K -$30.00K -$137.1K
YoY Change -97.91% -57.14% 585.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.819M $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.775M 640.0K $2.009M
YoY Change 38.11% 93.94% 12.89%
NET CHANGE
Cash From Operating Activities -$1.288M -800.0K -$1.512M
Cash From Investing Activities -$2.872K -30.00K -$137.1K
Cash From Financing Activities $2.775M 640.0K $2.009M
Net Change In Cash $1.485M -190.0K $360.3K
YoY Change 312.05% -62.75% -77.34%
FREE CASH FLOW
Cash From Operating Activities -$1.288M -$800.0K -$1.512M
Capital Expenditures $2.872K -$20.00K $137.1K
Free Cash Flow -$1.290M -$780.0K -$1.649M
YoY Change -21.75% 11.43% 783.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 ivda Cash Cdic Insured Limit
CashCdicInsuredLimit
3000000 TWD
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5953227 shares
CY2014Q1 us-gaap Noncurrent Assets
NoncurrentAssets
137129 USD
CY2015Q1 us-gaap Noncurrent Assets
NoncurrentAssets
-2872 USD
CY2014Q1 us-gaap Inventory Gross
InventoryGross
394427 USD
CY2014Q1 us-gaap Assets
Assets
4281313 USD
CY2015Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.5in; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px 0pt 0.25in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Concentrations</u></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments, which potentially subject us to concentrations of credit risk, consist principally of cash and cash equivalents and trade accounts receivable.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.7pt; MARGIN: 0pt 0px 0pt 54.6pt; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Substantially all cash is deposited in two financial institutions, one in the United States and one in Taiwan. At times, amounts on deposit in the United States may be in excess of the FDIC insurance limit. Deposits in Taiwan financial institutions are insured by CDIC (&#8220;Central Deposit Insurance Corporation&#8221;) with maximum coverage of NTD <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3</font> million. At times, amounts on deposit in Taiwan may be in excess of the CDIC insurance limit.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.7pt; MARGIN: 0pt 0px 0pt 54.6pt; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Accounts receivable are unsecured, and we are at risk to the extent such amount becomes uncollectible. We perform periodic credit evaluations of our customers&#8217; financial condition and generally do not require collateral. U.S.-based segment revenue from one customer represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 37</font>% of total revenue for the three months ended March 31, 2015, and three customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 89</font>% of the total U.S.-based segment accounts receivable at March 31, 2015. Taiwan-based segment revenue from one customer represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 76</font>% of total revenue for the three months ended March 31, 2015, and four customers represented approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 81</font>% of total Taiwan-based segment accounts receivable at March 31, 2015.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong><u>Reclassification</u></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0.75in; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain amounts in 2014 may have been reclassified to conform to the 2015 presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-756392 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4955301 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3484874 USD
CY2015Q1 us-gaap Revenues
Revenues
525821 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-848814 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
558331 USD
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1573958 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87900 USD
CY2015Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
888385 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
979095 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
573715 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
358804 USD
CY2015Q1 us-gaap Inventory Net
InventoryNet
469150 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
387918 USD
CY2015Q1 us-gaap Other Assets Current
OtherAssetsCurrent
694355 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
647659 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
4199563 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
2461376 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
445235 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
532512 USD
CY2015Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
121666 USD
CY2014Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
126666 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
188837 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
364320 USD
CY2015Q1 us-gaap Other Assets
OtherAssets
310503 USD
CY2014Q4 us-gaap Other Assets
OtherAssets
490986 USD
CY2015Q1 us-gaap Assets
Assets
4955301 USD
CY2014Q4 us-gaap Assets
Assets
3484874 USD
CY2015Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1959738 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2166246 USD
CY2015Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
430000 USD
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
575000 USD
CY2015Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
1113768 USD
CY2014Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1080500 USD
CY2015Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
75077 USD
CY2014Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
112009 USD
CY2015Q1 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
14151 USD
CY2014Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
34610 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
3592734 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3968365 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
273 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
273 USD
CY2015Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29850591 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
27261762 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34084 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35615 USD
CY2015Q1 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
492194 USD
CY2014Q4 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
492194 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28330045 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27490658 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
994581 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
271000 shares
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.16
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.03
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.77
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.09
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.98
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.99
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27308357 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27308357 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27308357 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27308357 shares
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.10
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
1.75
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
6106394 shares
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.98
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
6032519 shares
CY2015Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.99
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.1838 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0196 pure
CY2015Q1 ivda Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
7946212 shares
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-839387 USD
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26742623 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27308357 shares
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10879308 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13706369 shares
CY2014Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
210311 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
414523 USD
CY2015Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
98339 USD
CY2014Q1 us-gaap Revenues
Revenues
374864 USD
CY2014Q1 us-gaap Gross Profit
GrossProfit
164330 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
167126 USD
CY2014Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2234 USD
CY2015Q1 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
4443 USD
CY2014Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
11600 USD
CY2015Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
36932 USD
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3 USD
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
6083 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
56004 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
38031 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42167 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9427 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1405568 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-839387 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-1405568 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1801 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1531 USD
CY2014Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1407369 USD
CY2015Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-837856 USD
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
54324 USD
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57125 USD
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-880 USD
CY2015Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
19236 USD
CY2015Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2014Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
11600 USD
CY2015Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
36932 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
96000 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
62000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
38284 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
210479 USD
CY2014Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66051 USD
CY2015Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
79604 USD
CY2014Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
135472 USD
CY2015Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
34018 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-23641 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-231689 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1511936 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1287567 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
137129 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2872 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-137129 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2872 USD
CY2014Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-42417 USD
CY2015Q1 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-105255 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
2118141 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
16760 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5635 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-70114 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-145000 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-22605 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
-20812 USD
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
64074 USD
CY2015Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2818981 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2009400 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2775184 USD
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-5230 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1313 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
355105 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1486058 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
559729 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
914834 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
32105 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
37023 USD
CY2014Q1 ivda Discount On Convertible Debt
DiscountOnConvertibleDebt
51503 USD
CY2015Q1 ivda Discount On Convertible Debt
DiscountOnConvertibleDebt
0 USD
CY2014Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
55672 USD
CY2015Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
1527731 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
1015940 USD
CY2015Q1 ivda Dividends Payable Noncurrent
DividendsPayableNoncurrent
367986 USD
CY2014Q4 ivda Dividends Payable Noncurrent
DividendsPayableNoncurrent
272901 USD
CY2015Q1 ivda Total Price Of Cameras
TotalPriceOfCameras
1300000 USD
CY2014Q4 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
3600000 shares
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3085 USD
CY2014Q1 ivda Issuance Of Common Stock Warrants For Interest
IssuanceOfCommonStockWarrantsForInterest
0 USD
CY2015Q1 ivda Issuance Of Common Stock Warrants For Interest
IssuanceOfCommonStockWarrantsForInterest
7327 USD
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 USD
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-14005 USD
CY2014Q1 ivda Warrants Issued For Interest Expense
WarrantsIssuedForInterestExpense
0 USD
CY2015Q1 ivda Warrants Issued For Interest Expense
WarrantsIssuedForInterestExpense
7327 USD
CY2014Q1 ivda Inventory Valuation Allowance
InventoryValuationAllowance
0 USD
CY2015Q1 ivda Inventory Valuation Allowance
InventoryValuationAllowance
1000 USD

Files In Submission

Name View Source Status
0001144204-15-031315-index-headers.html Edgar Link pending
0001144204-15-031315-index.html Edgar Link pending
0001144204-15-031315.txt Edgar Link pending
0001144204-15-031315-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ivda-20150331.xml Edgar Link completed
ivda-20150331.xsd Edgar Link pending
ivda-20150331_cal.xml Edgar Link unprocessable
ivda-20150331_def.xml Edgar Link unprocessable
ivda-20150331_lab.xml Edgar Link unprocessable
ivda-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v410153_10q.htm Edgar Link pending
v410153_ex31-1.htm Edgar Link pending
v410153_ex31-2.htm Edgar Link pending
v410153_ex32-1.htm Edgar Link pending
v410153_ex32-2.htm Edgar Link pending